Physician
Keel and Associates
Keel and Associates was paid $495K by Medicaid between Jan 2018 and Nov 2024, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoKEEL AND ASSOCIATES
OXFORD, AL 36203
OXFORD, AL 36203
33aNPI1720136443assigned 01/08/2007
33bProvider typeGeneral Practice Physician
28Total paid$495K
24GClaims18,676
24DCodes billed23
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Practice Physician providers in Alabama
Rank by total paid#1 of 32
Median peer was paid$16K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,959 | $34K | |
| 2019 | 1,706 | $38K | |
| 2020 | 1,604 | $43K | |
| 2021 | 3,609 | $108K | |
| 2022 | 4,130 | $102K | |
| 2023 | 3,894 | $107K | |
| 2024incomplete | 1,774 | $63K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 2,658 | 2,195 | $179K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 3,023 | 2,610 | $117K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 9.8% | 2,824 | 2,502 | $49K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.6% | 1,863 | 1,646 | $43K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.6% | 3,026 | 2,716 | $33K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.9% | 225 | 201 | $24K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 469 | 416 | $16K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.2% | 166 | 153 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 1,662 | 1,389 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 1,058 | 908 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 112 | 66 | $2K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 72 | 70 | $1K |
11 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $810.17 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 378 | $516.72 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $451.00 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 28 | $176.13 |
| 80053 | Comprehensive metabolic panel | <1% | 12 | $36.00 |
| 36415 | Collection of venous blood by venipuncture | <1% | 13 | $24.00 |
| J0290 | Injection, ampicillin sodium, 500 mg | <1% | 14 | $18.39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $2.24 |
| 3078F | 0% | 394 | $0.00 | |
| 3074F | 0% | 595 | $0.00 | |
| 3079F | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARRINGTON, MYRA (BUSINESS MANAGER)